Sam Banister: Psychedelic Startups, Biotech, Drug Discovery, Psilocybin, DMT, Psychedelics & Society | M&M #79

Mind & Matter

English - July 14, 2022 04:00 - 1 hour - 50.1 MB - ★★★★★ - 15 ratings
Science Society & Culture science drugs psychedelics technology biotechnology innovation biology brain neuroscience startups Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Kevin Mitchell: Nature vs. Nurture, Neurogenetics, Personality, Autism, Schizophrenia, Synesthesia, Perception, Agency & Free Will | #78

Next Episode: Matt Ridley: The Origins of the SARS-CoV-2 Virus | #80

Nick talks to medicinal chemist Sam Banister, who is co-founder and Chief Science Officer at Psylo, a biotech startup focused on developing next-generation psychedelic medicines. They discuss: the past, present, and future of psychedelic science; Sam's journey from academia to biotech startup co-founder; Alexander Shulgin; psychedelics like psilocybin, DMT, and others; and psychedelics & society.

Support M&M:
Sign up for the weekly Mind & Matter newsletter
[https://mindandmatter.substack.com/?sort=top]

The Amino Co., shop science-back amino acids supplements. Use code ‘MIND’ to save 30%.
[aminoco.com/MIND]

Follow Nick's work through Linktree:
[https://linktr.ee/trikomes]

Organize your digital highlights & notes w/ Readwise (2 months free w/ sub)[https://readwise.io/nickjikomes/]

Learn more about our podcast sponsor, Dosist
[https://dosist.com]

Support the show